The KLOW Peptide Blend: What It Is and What Users Report
KLOW peptide explained: GHK-Cu, BPC-157, TB-500 and KPV in one research vial. What each part is, the evidence gap, label risk, and user reports.
Anonymous user report. Not medical advice. Peptides discussed are not FDA-approved for the uses described. Editorial process →
Short answer
"KLOW" is the GLOW blend (GHK-Cu, BPC-157, TB-500) with KPV added, marketed for skin, inflammation and healing. It is a research-labelled mix, not an approved medicine, and no trial has tested the four together. In a blend, a benefit or a reaction cannot be pinned on any one ingredient. Peptide Confessions does not publish dosing, timing, injection or sourcing guidance.
What KPV adds
KPV is a three-amino-acid fragment of alpha-MSH. In cell and animal studies it reduces inflammatory signalling, especially in models of colitis and skin inflammation. There are no meaningful human trials. Adding it to GLOW is a marketing step toward "anti-inflammatory", not evidence that the four work better together.
What users report
KLOW comes up more often than GLOW in confessions here. #395 only noticed after stopping that they had trained six days a week "with zero soreness". #709 noticed allergies easing but wasn't sure it was related. #147 credits a mix including KLOW with clearing years of scalp dermatitis. #662 reports better joints and healing but wonders whether it shortened how long their Botox lasts.
On the other side, #241 had a severe stomach illness the morning after a first injection and couldn't tell whether KLOW was the cause, the core problem with blends. #589 and #730 mention it as one part of a wider routine. Anecdotes, not rates.
Risks people raise
Label accuracy (see peptide testing), the well-known GHK-Cu injection sting, infection from non-sterile vials, and stacking four unapproved compounds at once. Persistent skin or gut disease needs a diagnosis, not a blend. See GLOW for the three-peptide version.
Last reviewed
October 15, 2026.
Related topics
related peptides:
community guides:
More confessions from the archive
Community Q&A
- What does KLOW do?
- It is marketed for skin, inflammation and recovery. Users describe less soreness or calmer skin, but no trial has tested the blend.
- Why does KLOW sting?
- Users commonly attribute the sting to GHK-Cu. Persistent pain, redness or swelling at an injection site can signal infection.
- Can you take KLOW with GLP-1s?
- There are no data on combining them. Talk to a clinician before mixing unapproved compounds with prescription drugs.
- What is in KLOW?
- GHK-Cu, BPC-157, TB-500 and KPV. Ratios vary and labels can be wrong — one test in this archive (#527) found far more GHK-Cu than stated.
- KLOW vs GLOW: what is the difference?
- KLOW adds KPV, a three-amino-acid anti-inflammatory fragment, to the GLOW trio.
- Is KLOW safe?
- Unknown. The blend has no clinical safety data, and none of the four parts is approved as an injectable medicine.
- Does Peptide Confessions give KLOW dosing?
- Peptide Confessions does not publish dosing, timing, injection or sourcing guidance.
- Why is KLOW peptide blue?
- The copper in GHK-Cu gives solutions a blue colour.
- Are peptides the same as Ozempic?
- Ozempic (semaglutide) is one approved peptide drug. KLOW is an unapproved blend of research peptides with no human trials.
Sources
Anonymous first-hand reports plus sourced context — educational only, not medical advice. Editorial policy & corrections.